CN1697650A - 非核苷类逆转录酶抑制剂 - Google Patents
非核苷类逆转录酶抑制剂 Download PDFInfo
- Publication number
- CN1697650A CN1697650A CNA038243377A CN03824337A CN1697650A CN 1697650 A CN1697650 A CN 1697650A CN A038243377 A CNA038243377 A CN A038243377A CN 03824337 A CN03824337 A CN 03824337A CN 1697650 A CN1697650 A CN 1697650A
- Authority
- CN
- China
- Prior art keywords
- substituted
- group
- low
- alkyl
- chemical compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
ID | EC50 | IC50 |
1 | A | A |
2 | A | A |
3 | B | A |
4 | C | A |
5 | C | A |
6 | B | A |
7 | B | A |
8 | B | A |
9 | B | A |
10 | C | N/D |
11 | C | N/D |
12 | C | N/D |
13 | C | N/D |
14 | C | N/D |
15 | C | N/D |
16 | C | N/D |
17 | C | N/D |
18 | C | N/D |
19 | C | N/D |
20 | C | N/D |
21 | C | N/D |
22 | C | N/D |
23 | C | N/D |
24 | C | N/D |
25 | C | N/D |
26 | B | N/D |
27 | C | N/D |
28 | C | N/D |
29 | C | B |
30 | C | N/D |
31 | C | N/D |
32 | C | N/D |
33 | C | B |
34 | C | B |
35 | C | N/D |
38 | C | N/D |
37 | C | N/D |
38 | N/D | B |
39 | C | N/D |
40 | C | B |
41 | C | B |
42 | C | N/D |
43 | C | B |
44 | C | B |
45 | C | 36.27 |
46 | C | C |
47 | C | N/D |
48 | C | N/D |
49 | C | N/D |
50 | C | N/D |
51 | C | N/D |
52 | C | B |
ID | EC50 | IC50 |
1 | A | A |
2 | A | A |
3 | A | A |
4 | A | A |
5 | A | A |
6 | A | A |
7 | A | A |
8 | A | A |
9 | A | A |
10 | A | A |
11 | A | A |
12 | A | A |
13 | A | A |
14 | A | A |
15 | A | A |
16 | A | A |
17 | A | A |
18 | A | A |
19 | A | A |
20 | A | A |
21 | A | A |
Claims (48)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
USPCT/US02/26816 | 2002-08-23 | ||
US0226816 | 2002-08-23 | ||
PCT/US2003/027433 WO2004030611A2 (en) | 2002-08-23 | 2003-08-22 | Non-nucleoside reverse transcriptase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1697650A true CN1697650A (zh) | 2005-11-16 |
CN1697650B CN1697650B (zh) | 2010-11-10 |
Family
ID=32067653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN038243377A Expired - Fee Related CN1697650B (zh) | 2002-08-23 | 2003-08-22 | 非核苷类逆转录酶抑制剂 |
Country Status (14)
Country | Link |
---|---|
US (2) | US20060135556A1 (zh) |
EP (2) | EP2353593B1 (zh) |
JP (1) | JP4413781B2 (zh) |
CN (1) | CN1697650B (zh) |
AT (1) | ATE504294T1 (zh) |
AU (2) | AU2003295324B2 (zh) |
BR (1) | BR0313747A (zh) |
CA (1) | CA2496565C (zh) |
DE (1) | DE60336664D1 (zh) |
EA (1) | EA009478B1 (zh) |
HK (1) | HK1085667A1 (zh) |
MX (1) | MXPA05002070A (zh) |
WO (1) | WO2004030611A2 (zh) |
ZA (1) | ZA200502384B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101899013A (zh) * | 2010-07-12 | 2010-12-01 | 山东大学 | 2-(2-取代芳基-2h-1,2,4-三唑-3-巯基)乙酰胺衍生物及其制备方法与应用 |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA05002070A (es) * | 2002-08-23 | 2005-07-05 | Ribapharm Inc | Inhibidores no nucleosidicos de la transcriptasa inversa. |
US7642277B2 (en) | 2002-12-04 | 2010-01-05 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
GB0315111D0 (en) | 2003-06-27 | 2003-07-30 | Cancer Rec Tech Ltd | Substituted 5-membered ring compounds and their use |
JP2007527919A (ja) * | 2004-03-08 | 2007-10-04 | ワイス | イオンチャンネルモジュレーター |
WO2005090320A2 (en) * | 2004-03-12 | 2005-09-29 | Wyeth | Triazole derivatives and method of using the same to treat hiv infections |
WO2005115147A2 (en) * | 2004-05-18 | 2005-12-08 | Merck & Co., Inc. | Hiv reverse transcriptase inhibitors |
US7517998B2 (en) | 2004-06-01 | 2009-04-14 | Boehringer Ingelheim International Gmbh | Non nucleoside reverse transcriptase inhibitors |
WO2007050087A1 (en) * | 2004-08-25 | 2007-05-03 | Ardea Biosciences, Inc. | N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS |
NZ553534A (en) * | 2004-08-25 | 2010-10-29 | Ardea Biosciences Inc | S-triazolyl alpha-mercaptoacetanildes as inhibitors of HIV reverse transcriptase |
SG174016A1 (en) * | 2006-07-24 | 2011-09-29 | Korea Res Inst Chem Tech | Hiv reverse transcriptase inhibitors |
WO2009030996A1 (en) * | 2007-09-05 | 2009-03-12 | Coley Pharmaceutical Group, Inc. | Triazole compounds as toll-like receptor (tlr) agonists |
ME01294B (me) * | 2007-11-27 | 2013-06-20 | Ardea Biosciences Inc | Nova jedinjenja i kompozicije i metode upotrebe |
US8242154B2 (en) | 2008-09-04 | 2012-08-14 | Ardea Biosciences, Inc. | Compounds, compositions and methods of using same for modulating uric acid levels |
US8173690B2 (en) | 2008-09-04 | 2012-05-08 | Ardea Biosciences, Inc. | Compounds, compositions and methods of using same for modulating uric acid levels |
KR20110050708A (ko) * | 2008-09-04 | 2011-05-16 | 아디아 바이오사이언스즈 인크. | 요산 수치를 조절하기 위한 화합물, 조성물 및 이들의 사용 방법 |
EP2432468A2 (en) | 2009-05-20 | 2012-03-28 | Ardea Biosciences, Inc. | Methods of modulating uric acid levels |
CA2767541A1 (en) * | 2009-07-10 | 2011-04-21 | Microbiotix, Inc. | Inhibitors of filovirus entry into host cells |
JP5984218B2 (ja) * | 2010-07-02 | 2016-09-06 | ギリアード サイエンシーズ, インコーポレイテッド | Aidsを処置するためのナフト−2−イル酢酸誘導体 |
WO2012061039A2 (en) | 2010-10-25 | 2012-05-10 | Vanderbilt University | Compositions for inhibition of insect host sensing |
CA2835328C (en) * | 2011-05-06 | 2019-10-15 | Vanderbilt University | Compositions for inhibition of insect sensing |
ITMI20120786A1 (it) * | 2012-05-09 | 2013-11-10 | Fond Italiana Sclerosi M Ultipla Fism Onlu | Modulatori del recettore gpr17 |
AR091651A1 (es) | 2012-07-03 | 2015-02-18 | Ardea Biosciences Inc | Elaboracion de acido 2-(5-bromo-4-(4-ciclopropilnaftalen-1-il)-4h-1,2,4-triazol-3-iltio)acetico |
RU2626003C2 (ru) * | 2014-04-28 | 2017-07-21 | Общество с ограниченной ответственностью "Квантум Фармасьютикалс" | Амид 1,2,4-триазол-3-илтиогликолевой кислоты, обладающий противовирусной активностью, или его фармацевтически приемлемые соли, фармацевтические композиции и их применение для лечения и профилактики гриппа |
US10791739B2 (en) | 2015-03-25 | 2020-10-06 | Vanderbilt University | Binary compositions as disruptors of orco-mediated odorant sensing |
LT3300500T (lt) | 2015-05-20 | 2020-05-25 | Amgen Inc. | Apj receptoriaus triazolo agonistai |
EP3452466B1 (en) | 2016-05-03 | 2020-08-12 | Amgen Inc. | Heterocyclic triazole compounds as agonists of the apj receptor |
WO2018097944A1 (en) | 2016-11-16 | 2018-05-31 | Amgen Inc. | Triazole furan compounds as agonists of the apj receptor |
WO2018093579A1 (en) | 2016-11-16 | 2018-05-24 | Amgen Inc. | Triazole phenyl compounds as agonists of the apj receptor |
WO2018093577A1 (en) | 2016-11-16 | 2018-05-24 | Amgen Inc. | Cycloalkyl substituted triazole compounds as agonists of the apj receptor |
WO2018093580A1 (en) | 2016-11-16 | 2018-05-24 | Amgen Inc. | Triazole pyridyl compounds as agonists of the apj receptor |
EP3541805B1 (en) | 2016-11-16 | 2020-10-14 | Amgen Inc. | Heteroaryl-substituted triazoles as apj receptor agonists |
WO2018093576A1 (en) | 2016-11-16 | 2018-05-24 | Amgen Inc. | Alkyl substituted triazole compounds as agonists of the apj receptor |
EP3704122B1 (en) | 2017-11-03 | 2021-09-01 | Amgen Inc. | Fused triazole agonists of the apj receptor |
EP3788037A1 (en) | 2018-05-01 | 2021-03-10 | Amgen Inc. | Substituted pyrimidinones as agonists of the apj receptor |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0759563B2 (ja) * | 1987-01-28 | 1995-06-28 | 大塚化学株式会社 | ピラゾ−ル誘導体、その製造方法及び該誘導体を有効成分とする除草剤 |
EP0303301A3 (en) * | 1987-08-14 | 1989-05-17 | Fuji Photo Film Co., Ltd. | Silver halide photographic material |
US6832996B2 (en) * | 1995-06-07 | 2004-12-21 | Arthrocare Corporation | Electrosurgical systems and methods for treating tissue |
EP0910565A1 (en) | 1997-02-14 | 1999-04-28 | Bayer Corporation | Amide derivatives as selective neuropeptide y receptor antagonists |
US6245817B1 (en) * | 1997-02-14 | 2001-06-12 | Bayer Corporation | NPY5 receptor antagonists and methods for using same |
BRPI9909191B8 (pt) * | 1998-03-27 | 2021-07-06 | Janssen Pharmaceutica Nv | derivados de pirimidina inibidores do hiv, seu uso e composição farmacêutica que os compreende |
US6414147B1 (en) * | 1998-12-23 | 2002-07-02 | Neurogen Corporation | 2-amino-9-alkylpurines: GABA brain receptor ligands |
US6593077B2 (en) * | 1999-03-22 | 2003-07-15 | Special Materials Research And Technology, Inc. | Method of making thin films dielectrics using a process for room temperature wet chemical growth of SiO based oxides on a substrate |
CN1494528A (zh) | 2001-03-02 | 2004-05-05 | ʷ��˿�������ȳ�ķ����˾ | 作为逆转录酶抑制剂的二苯酮 |
MXPA05002070A (es) * | 2002-08-23 | 2005-07-05 | Ribapharm Inc | Inhibidores no nucleosidicos de la transcriptasa inversa. |
US7642277B2 (en) * | 2002-12-04 | 2010-01-05 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
US20060205026A1 (en) * | 2002-12-19 | 2006-09-14 | Valeant Research & Development | Parallel inducible cell-based kinase screen |
WO2007050087A1 (en) * | 2004-08-25 | 2007-05-03 | Ardea Biosciences, Inc. | N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS |
US8101799B2 (en) * | 2005-07-21 | 2012-01-24 | Ardea Biosciences | Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK |
WO2007121269A2 (en) * | 2006-04-11 | 2007-10-25 | Ardea Biosciences, Inc. | N-aryl-n'alkyl sulfamides as mek inhibitors |
CA2649122C (en) * | 2006-04-18 | 2015-06-30 | Ardea Biosciences, Inc. | Pyridone sulfonamides and pyridone sulfamides as mek inhibitors |
WO2008058285A2 (en) * | 2006-11-09 | 2008-05-15 | Ardea Biosciences, Inc. | 4-cyanophenylamino-substituted bicyclic heterocyclic compounds as hiv inhibitors |
-
2003
- 2003-08-22 MX MXPA05002070A patent/MXPA05002070A/es active IP Right Grant
- 2003-08-22 JP JP2004541500A patent/JP4413781B2/ja not_active Expired - Fee Related
- 2003-08-22 AT AT03786506T patent/ATE504294T1/de not_active IP Right Cessation
- 2003-08-22 EA EA200500399A patent/EA009478B1/ru not_active IP Right Cessation
- 2003-08-22 EP EP11160994A patent/EP2353593B1/en not_active Expired - Lifetime
- 2003-08-22 DE DE60336664T patent/DE60336664D1/de not_active Expired - Lifetime
- 2003-08-22 US US10/526,249 patent/US20060135556A1/en not_active Abandoned
- 2003-08-22 CA CA2496565A patent/CA2496565C/en not_active Expired - Fee Related
- 2003-08-22 CN CN038243377A patent/CN1697650B/zh not_active Expired - Fee Related
- 2003-08-22 BR BR0313747-3A patent/BR0313747A/pt not_active Application Discontinuation
- 2003-08-22 EP EP03786506A patent/EP1545483B1/en not_active Expired - Lifetime
- 2003-08-22 AU AU2003295324A patent/AU2003295324B2/en not_active Ceased
- 2003-08-22 WO PCT/US2003/027433 patent/WO2004030611A2/en active Application Filing
-
2005
- 2005-03-22 ZA ZA200502384A patent/ZA200502384B/en unknown
-
2006
- 2006-05-16 HK HK06105685.3A patent/HK1085667A1/xx not_active IP Right Cessation
-
2008
- 2008-05-02 US US12/114,467 patent/US20080249131A1/en not_active Abandoned
- 2008-11-19 AU AU2008246249A patent/AU2008246249B2/en not_active Ceased
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101899013A (zh) * | 2010-07-12 | 2010-12-01 | 山东大学 | 2-(2-取代芳基-2h-1,2,4-三唑-3-巯基)乙酰胺衍生物及其制备方法与应用 |
CN101899013B (zh) * | 2010-07-12 | 2012-07-25 | 山东大学 | 2-(2-取代芳基-2h-1,2,4-三唑-3-巯基)乙酰胺衍生物及其制备方法与应用 |
Also Published As
Publication number | Publication date |
---|---|
EA200500399A1 (ru) | 2005-12-29 |
EP2353593B1 (en) | 2012-08-22 |
US20080249131A1 (en) | 2008-10-09 |
AU2008246249B2 (en) | 2010-09-30 |
US20060135556A1 (en) | 2006-06-22 |
AU2003295324B2 (en) | 2008-08-28 |
HK1085667A1 (en) | 2006-09-01 |
ZA200502384B (en) | 2007-03-28 |
BR0313747A (pt) | 2005-06-21 |
WO2004030611A3 (en) | 2004-06-17 |
ATE504294T1 (de) | 2011-04-15 |
MXPA05002070A (es) | 2005-07-05 |
CA2496565C (en) | 2013-04-02 |
EA009478B1 (ru) | 2008-02-28 |
JP4413781B2 (ja) | 2010-02-10 |
EP1545483A4 (en) | 2009-03-25 |
EP1545483B1 (en) | 2011-04-06 |
EP2353593A1 (en) | 2011-08-10 |
CN1697650B (zh) | 2010-11-10 |
CA2496565A1 (en) | 2004-04-15 |
AU2003295324A1 (en) | 2004-04-23 |
AU2008246249A1 (en) | 2008-12-11 |
JP2006505543A (ja) | 2006-02-16 |
WO2004030611A2 (en) | 2004-04-15 |
DE60336664D1 (de) | 2011-05-19 |
EP1545483A2 (en) | 2005-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1697650A (zh) | 非核苷类逆转录酶抑制剂 | |
Hodge et al. | Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450 | |
CN1168733C (zh) | 新的用于治疗肿瘤和炎症疾病的前药 | |
CN1217660C (zh) | Il-8受体拮抗剂 | |
US9061999B2 (en) | Compounds useful for treating AIDS | |
CN1745077A (zh) | 促旋酶抑制剂及其用途 | |
CN1304389C (zh) | 可用作ccr5拮抗剂的哌啶衍生物 | |
CN1505625A (zh) | 用于治疗由过度细胞因子活性引起的疾病的三唑化合物 | |
CN1934092A (zh) | 非核苷逆转录酶抑制剂 | |
CN1409711A (zh) | 用作hiv逆转录酶抑制剂的稠合的二氮萘化合物 | |
CN1208405A (zh) | 逆病毒蛋白酶抑制化合物 | |
CN1720043A (zh) | 非核苷逆转录酶抑制剂 | |
CN1185737A (zh) | 异噻唑酮类化合物 | |
CN1692109A (zh) | 作为ns3-丝氨酸蛋白酶抑制剂的脯氨酸化合物用于治疗丙型肝炎病毒感染 | |
CN1094055A (zh) | 天冬氨酰蛋白酶的新的抑制剂 | |
CN1214339A (zh) | 吡唑衍生物、其制备方法和在药物中的应用 | |
CN1310179A (zh) | 作为impdh抑制剂的草酰胺 | |
CN1659147A (zh) | 哒嗪衍生物 | |
CN1894215A (zh) | 治疗细胞增殖疾病的化合物 | |
CN1653067A (zh) | 咔唑衍生物及其作为神经肽y5受体拮抗剂的应用 | |
CN1585770A (zh) | 回折模拟物及其相关的方法 | |
CN1160402A (zh) | 用作pnp抑制剂的嘌呤和鸟嘌呤化合物 | |
CN1216982A (zh) | 含氮三环化合物和含有该化合物的药物 | |
CN1387517A (zh) | 作为环加氧酶-2抑制剂的5-芳基-1h-1,2,4-三唑化合物及含有它们的药物组合物 | |
CN1711236A (zh) | 基于硝基苯胺的烷化剂和它们作为前体药物的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1085667 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: ADIA LIFE SCIENCE CO.,LTD. Free format text: FORMER OWNER: RIBAPHARM INC. Effective date: 20071012 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20071012 Address after: California, USA Applicant after: ARDEA BIOSCIENCES, Inc. Address before: California, USA Applicant before: Valeant Pharmaceuticals North America |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1085667 Country of ref document: HK |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101110 Termination date: 20210822 |
|
CF01 | Termination of patent right due to non-payment of annual fee |